Kenichi Harano

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

Yuko Tanabe, Kenji Hashimoto, Chikako Shimizu et al. · International Journal of Clinical Oncology · 2011 · 156 citations

Breast Oncology, Oncology, Pharmacology +6

Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358

R. Wendel Naumann, Ana Oaknin, Tim Meyer et al. · Annals of Oncology · 2019 · 89 citations · Full text

Checkmate 358, Cervical Cancer, Medicine +7

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 89 citations

Gynecological Surgery, Medicine, Metronomic Therapy +6

TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)

Akihito Kawazoe, Kota Itahashi, Noboru Yamamoto et al. · Clinical Cancer Research · 2021 · 64 citations · Full text

Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group

Kenichi Harano, Akihiro Hirakawa, Mayu Yunokawa et al. · International Journal of Clinical Oncology · 2015 · 61 citations

Prognostic Factors, Gynecological Surgery, Medicine +9